期刊文献+

软组织肉瘤MRI影像学特征与Ki-67表达水平的相关性研究 被引量:2

Assessment of MRI features correlating with Ki-67 labeling index in soft tissue sarcoma
下载PDF
导出
摘要 目的:探讨软组织肉瘤MRI影像特征与其Ki-67表达水平的相关性。方法:搜集48例临床或影像疑似软组织肉瘤的患者,均行3.0T MRI扫描,扫描序列包括常规T_(1)WI平扫、T_(2)WI平扫及T_(1)WI增强扫描,其中25例行扩散加权成像(DWI)检查。由2位影像诊断医师评估常规影像学特征,同时测量病变区域的ADC平均值(ADCmean)及ADC最小值(ADCmin)。Ki-67≥30%为高表达组,Ki-67<30%为低表达组。采用受试者工作特征(ROC)曲线评估软组织肉瘤各影像学特征对Ki-67高表达与低表达的鉴别诊断效能。结果:48例软组织肉瘤中22例Ki-67低表达,26例Ki-67高表达。瘤周强化鉴别诊断Ki-67高表达与Ki-67低表达的曲线下面积(AUC)为0.855,敏感度与特异度分别为85%、86%;平扫T_(2)信号不均匀性(≥50%)鉴别诊断Ki-67高表达与Ki-67低表达的AUC为0.710,敏感度与特异度分别为69%、72%;肿瘤边界鉴别诊断Ki-67高表达与Ki-67低表达的AUC为0.692,敏感度与特异度分别为77%、56%。软组织肉瘤Ki-67高表达组与Ki-67低表达组的ADCmean值、ADCmin值差异均有统计学意义(P<0.05),且Ki-67高表达组的ADCmean值、ADCmin值均低于Ki-67低表达组,ADCmean值、ADCmin值与其Ki-67表达水平均呈负相关。ADCmean阈值为1.332×10^(-3)mm^(2)/s时,敏感度与特异度分别为85%、73%;ADCmin阈值为0.883×10^(-3)mm^(2)/s时,敏感度与特异度分别为89%、78%。结论:软组织肉瘤的常规影像学特征中瘤周强化、T_(2)信号不均匀性、肿瘤边界与其Ki-67表达水平相关,其中瘤周强化的诊断效能最高。ADCmean及ADCmin值可用于鉴别软组织肉瘤Ki-67高表达与Ki-67低表达。 Objective:To examine the correlation of MRI features with Ki-67 labeling index(LI)in soft tissue sarcoma(STS).Methods:Forty-eight patients with clinically diagnosed STS in our hospital underwent 3.0T MRI,including T_(1)WI,T_(2)WI,enhanced T_(1)WI examination and 25 patients underwent diffusion-weighted imaging(DWI).The conventional MRI features,mean and minimum apparent diffusion coefficients(ADCs)(ADCmean and ADCmin,respectively)of each lesion were independently analyzed by two readers.STS were considered high-proliferation if≥30%of nuclei were stained while low-proliferation if<30%of nuclei were stained.Their relationship with the Ki-67 LI was examined using ROC analyses.Results:Among 48 lesions,22 and 26 were categorized into the low-and high-proliferation groups,respectively.Three MRI features,including peritumoral enhancement,margin definitions and heterogeneous signal intensities greater than or equal to 50%at T_(2)-weighted imaging,were associated with Ki-67 LI.The sensitivity,specificity,and area under the curve of peritumoral enhancement for differentiating low-and high-proliferation groups were 85%,86%,and 0.855.The sensitivity,specificity,and area under the curve of heterogeneous signal intensities greater than or equal to 50%at T_(2)-weighted imaging for differentiating low-and high-proliferation groups were 69%,72%,and 0.710.The sensitivity,specificity,and area under the curve of Margin definitions for differentiating low-and high-proliferation groups were 77%,56%,and 0.692.A statistical difference between ADCmean and ADCmin was found in high-proliferation group and low-proliferation group.The ADCmean and ADCmin of the high-proliferation group were significantly lower than that of the low-proliferation group.A cut-off ADCmean value of 1.332×10^(-3)mm^(2)/s was used,the sensitivity and specificity for differentiating low-and high-proliferation groups were 85%,73%.A cut-off ADCmin value of 0.883×10^(-3)mm^(2)/s was used,the sensitivity and specificity for differentiating low-and high-proliferation groups were 89%,78%.Conclusion:Peritumoral enhancement,heterogeneous signal intensities greater than or equal to 50%at T_(2)-weighted imaging and Margin definitions were associated with Ki-67 LI,and Peritumoral enhancement was with the best diagnostic performance.ADCmean and ADCmin were correlated with Ki-67 LI and could help differentiate STS with low or high proliferation potential.
作者 徐磊 祁良 邹月芬 韦永中 XU Lei;QI Liang;ZOU Yue-fen(department of Radiology,the First Affiliated Hospital of Nanjing Medical University(Jiangsu Provincial People's Hospital),Nanjing 210029,China)
出处 《放射学实践》 CSCD 北大核心 2022年第9期1127-1131,共5页 Radiologic Practice
关键词 软组织肉瘤 磁共振成像 扩散加权成像 KI-67 Soft tissue sarcoma Magnetic resonance imaging Diffusion weighted imaging Ki-67
  • 相关文献

参考文献5

二级参考文献31

  • 1Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation [J]. Int J Cancer, 1983, 31 ( 1 ) : 13-20.
  • 2Nishimura R, Osako T, Okumura Y, et al. Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer [J]. Exp Ther Med, 2010,1(5) :747-754.
  • 3Molino A, Micciolo R, Turazza M, et al. Ki-67 immunostaining in 322 primary breast cancers: associations with clinical and pathological variables and prognosis [J]. Int J Cancer, 1997, 74 (4) :433437.
  • 4Locker AP, Birrell K, Bell JA, et al. Ki67 immunoreactivity in breast carcinoma: relationships to prognostic variables and short term survival[J]. Eur J Surg Oncol, 1992, 18(3) :224-229.
  • 5Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[J]. Nature, 2000, 406(6797) :747-752.
  • 6Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets [J]. Proc Natl Acad Sci USA, 2003,100(14) :8418-8423.
  • 7Railo M, Nordling S, von Boguslawsky K, et al. Prognostic value of Ki-67 iinmunolabelling in primary operable breast cancer [J] . Br J Cancer, 1993, 68 (3) :579-583.
  • 8Cheang MC, Chia SK, Voduc D, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer [J]. J Natl Cancer Inst, 2009, 101 (10) : 736-750.
  • 9Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes: dealing with the diversity of breast cancer: highlights of the SI. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [J]. Ann Oncol, 2011, 22(8) :1736- 1747.
  • 10Viale G, Giobbie-Hurder A, Regan MM, et al. Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole [J]. J Clin Oncol, 2008, 26 (34) :5569-5575.

共引文献104

同被引文献16

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部